Clinical Trial

PDT For Induction Therapy For Head And Neck Cancer

Name: PDT For Induction Therapy For Head And Neck Cancer — clinical trial record (NCT07214987)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This research study is being done to assess the safety and tolerability of toripalimab in combination with cisplatin and docetaxel (PDT) induction therapy for patients with CPS-positive locally advanced head and neck squamous cell carcinoma (HNSCC).

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-15

Trial Details

NCT Number	NCT07214987
Lead Sponsor	Massachusetts General Hospital Collaborators: Coherus Oncology, Inc.
Conditions	Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer
Enrollment	26 participants
Start Date	2026-03-09
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-14